Financial Architects (New Jersey)’s Fortress Biotech FBIO Stock Holding History

Financial Architects (New Jersey)’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-27	Closed	-$1K	–	1290
2019 Q1	$1K	Hold	27	–	–	﹤0.01%	1365
2018 Q4	$0	Hold	27	–	–	﹤0.01%	1378
2018 Q3	$1K	Hold	27	–	–	﹤0.01%	1362
2018 Q2	$1K	Hold	27	–	–	﹤0.01%	1251
2018 Q1	$2K	Hold	27	–	–	﹤0.01%	1322
2017 Q4	$2K	Hold	27	–	–	﹤0.01%	1404
2017 Q3	$2K	Hold	27	–	–	﹤0.01%	1406
2017 Q2	$2K	Hold	27	–	–	﹤0.01%	1422
2017 Q1	$1K	Hold	27	–	–	﹤0.01%	1512
2016 Q4	$1K	Hold	27	–	–	﹤0.01%	1344
2016 Q3	$1K	Hold	27	–	–	﹤0.01%	1405
2016 Q2	$1K	Buy	+27	New	+$1.26K	﹤0.01%	1395

Other funds holding FBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OPPM

Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Financial Architects (New Jersey)'s FBIO Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Fortress Biotech (FBIO) in Q2 2019, closing a stake of 27 shares — an estimated $1K sold.

Financial Architects (New Jersey) first reported a position in FBIO in Q2 2016 and held it in 12 quarters. The position peaked at $2K in Q1 2018. 49 funds tracked by Wall St. Rank hold FBIO as of Q2 2019.

Financial Architects (New Jersey) reported no remaining Fortress Biotech position as of Q2 2019 after selling out during the quarter.
Financial Architects (New Jersey) sold 27 Fortress Biotech shares in Q2 2019, an estimated $1K.
Financial Architects (New Jersey) first reported a position in Fortress Biotech in Q2 2016 and held it in 12 quarters.
Financial Architects (New Jersey)'s Fortress Biotech position peaked at $2K in Q1 2018.
49 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.